The creation of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, involves a complex complicated synthetic process. Preliminary routes focused on protein fragment coupling, utilizing https://saadpjsd336243.dbblog.net/13982787/synthesis-and-investigation-implementations-of-retatrutide